高齢者のための州レベルの処方箋計画における皮膚経由のニコチンの使用. "現実世界"のパッチユーザーを初めて見ました
1Fox Chase Cancer Center, Cheltenham, PA 19012.
JAMA
|February 23, 1994
まとめ
ニコチンパッチを使用している高齢の喫煙者は29%の禁煙率を持っていたが,従順性は低かった. 医師と薬剤師との接触が増えたことで,皮膚経由のニコチン療法の結果が改善されました.
科学分野:
- ゲロントロジーはゲロントロジーの学科です.
- 依存症医学 薬物中毒医学
- 公衆衛生は公衆衛生である.
背景:
- 低所得高齢者は,喫煙に関連する健康問題に対して脆弱な人口です.
- 皮膚経由のニコチンパッチは,この人口集団にとって,潜在的な禁煙支援を提供している.
研究 の 目的:
- 経皮ニコチン療法の使用パターンと有効性を評価する.
- 高齢で低所得の喫煙者の禁煙に影響を与える要因を特定する.
主な方法:
- 1070人の高齢喫煙者 (65-74歳) を対象に6ヶ月の電話調査を実施した.
- 参加者は,ペンシルベニア州高齢者向け医薬品支援計画 (Pennsylvania's Pharmaceutical Assistance Plan for the Elderly) を通じて,皮膚経由のニコチン処方箋を記入しました.
- 収集されたデータには,医師/薬剤師の助言,補助的な治療,同時に喫煙,および6ヶ月の禁煙が含まれています.
主要な成果:
- 回答者は長期にわたる重度の喫煙者であり,平均5週間パッチを使用していました.
- 29%の自己報告された6ヶ月の禁煙率が観察されました.
- 54%が初期カウンセリングを受け,2%が正式なプログラムを使用し,47%がパッチを使用しながら喫煙した. 同時に喫煙することは,禁欲の失敗と関連していた (P < .001).
結論:
- ニコチンパッチ療法は高齢者にとって有望ですが,遵守と最適な使用には注意が必要です.
- 医療従事者との頻繁な接触は,同時喫煙の減少と,禁煙率の上昇と相関していた (P = .005).
- この集団の治療戦略を洗練するためにさらなる研究が必要である.
さらに関連する動画
06:12Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
06:33Fabrication of Dissolvable Microneedle Patches Loaded with α-Lactalbumin Nanomicelles for Transdermal Capsaicin Delivery and Adipose Tissue Reduction
Published on: December 30, 2025
関連する概念動画
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
